NKG2D (NK cell‐activated receptor NK group 2, member D) is an activation receptor for NK, NKT, and CD8+ T cells, and its aberrant loss in cancer is a key mechanism of immune evasion, and NKG2D may be an exosome‐mediated immune evasion in cancer. This evidence concerns the gene CD8A and cancer.